Codice QR

Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience

Background: Dupilumab is a new targeted therapy for severe atopic dermatitis (AD) with limited real-world evidence. Objective: Explore our experience with dupilumab for AD in clinical practice at a tertiary care center. Material and method: Unicentric observational retrospective study including adul...

Descrizione completa

Salvato in:
Autori principali: A. Martínez-Doménech, V. Zaragoza-Ninet, A. Esteve-Martínez, A. García-Rabasco, J.L. Sánchez-Carazo, A. Pérez-Ferriols
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2024-02-01
Serie:Actas Dermo-Sifiliográficas
Soggetti:
Dermatitis atópica
Tratamiento dermatológico
Dupilumab
Eccema
Práctica clínica
Accesso online:http://www.sciencedirect.com/science/article/pii/S0001731023008189
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi